Synthetic Cannabinoid Case Study: Endometriosis
Time: 3:30 pm
day: Day One - Afternoon
Details:
- Understanding the development of synthetic cannabinoids through advanced AI platforms and in silico modelling to design novel synthetic compounds
- Illustrating how these compounds bind to CB1 and CB2 receptors and how their activity can be biased
- A case study to explore the connection between the endocannabinoid system and endometriosis, emphasizing cannabinoid intervention as a promising yet under-researched therapeutic approach
NEW DATA
